Hyderabad, December 5, 2022:
MapmyGenome, a preventive genomics company, has launched its pharmacogenomics solution MedicaMap™.
MedicaMap is a cutting-edge pharmacogenomic solution that analyses an individual's response to medicines based on their genetic makeup. It covers over 165 US FDA-approved drugs across 12 different specialties — including psychiatry, oncology, cardiology, and diabetology.
MedicaMap provides an easy-to-read comprehensive report on medicines' toxicity and efficacy for a person. It guides clinicians to identify alternate medicines or adjust dosage according to an individual's genetic profile for the prevention, diagnosis, and treatment of health conditions.
The test covers commonly used medicines like metformin, clopidogrel, warfarin, and codeine — drugs widely prescribed to Indian patients. It is an affordable, non-invasive, once-in-a-lifetime test that can be done from home.
MapmyGenome CEO Anu Acharya said: "MedicaMap is a one-of-a-kind pharmacogenomic product that provides you a detailed analysis of your body's response to medicine based on your genetic makeup. It is an affordable, non-invasive, once-in-a-lifetime test. You can do it from your own home. We have introduced it at ₹6,499 for over 165 drugs, which is probably the lowest price."
Read the full coverage in Telangana Today →
Stop Guessing. Start Knowing.
MedicaMap™ by MapmyGenome reveals how your body processes 165+ medications — so your doctor can prescribe the right drug at the right dose from day one. At-home saliva test. NABL & CAP accredited lab. Genetic counselling included.
